Combined adjuvant-delivery system for new generation vaccine antigens: alliance has its own advantage
- 11 October 2018
- journal article
- review article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup3) , 818-831
Abstract
Vaccines are a significant historical accomplishment in medical science due to its significance in saving millions of lives around the world with a manifold decline in disease burden and health expenditure. Since last decade, extensive efforts in vaccine design based on rational and experimental set up prompts the acknowledgement of several protective antigens; however, the utilization of those antigens as intense safe vaccines is still far beyond their discovery. The advancement of accomplished vaccines will need the combination of numerous strategies. In this way, the vaccine can be capable of provoking an abundant and effective immunization to compete against antigens with minimal/no adverse effects on recipients. First, stable and striking enough on the pharmaceutical point of view. Second, application of rational and realistic approaches to select an appropriate combination of adjuvant, antigen and delivery vehicle in the suitable formulation. Different vaccine adjuvants-delivery system combinations were discussed here elaborately, which are approved/licensed for human vaccines and are in various phases of clinical trials and pre-clinical trials. Challenges/limitations associated with vaccine designing and parameters to be considered, approaches to be applied, using available adjuvants are also detailed.Keywords
Funding Information
- University Grants Committee
- University Grants Commission.
This publication has 43 references indexed in Scilit:
- An Overview of Novel Adjuvants Designed for Improving Vaccine EfficacyTrends in Pharmacological Sciences, 2017
- An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulatorsExpert Review of Vaccines, 2017
- Nanoparticulate mediated transcutaneous immunization: Myth or realityNanomedicine: Nanotechnology, Biology and Medicine, 2016
- Sizing the optimal dimensions of a vaccine delivery system: a particulate matterExpert Opinion on Drug Delivery, 2015
- Recent Advances in Peptide-Based Subunit NanovaccinesNanomedicine, 2014
- Development and Evaluation of a Novel Mucus Diffusion Test System Approved by Self-Nanoemulsifying Drug Delivery SystemsJournal of Pharmaceutical Sciences, 2013
- Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune propertiesJournal of Controlled Release, 2013
- Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigensInternational Journal of Pharmaceutics, 2008
- Implication of nanoparticles/microparticles in mucosal vaccine deliveryExpert Review of Vaccines, 2007
- Recent advances in the discovery and delivery of vaccine adjuvantsNature Reviews Drug Discovery, 2003